EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for HYPD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 0.9232
March 31, 2026 0.255
December 31, 2025 -4.673
September 30, 2025 0.0544
June 30, 2025 -2.497
March 31, 2025 -1.591
December 31, 2024 -17.50
September 30, 2024 -0.1134
June 30, 2024 -0.2081
March 31, 2024 -0.2344
December 31, 2023 -0.1755
September 30, 2023 -0.1828
June 30, 2023 -0.1632
March 31, 2023 -0.1534
December 31, 2022 -0.1668
September 30, 2022 -0.211
June 30, 2022 -0.2152
March 31, 2022 -0.2446
December 31, 2021 0.0994
Date Value
September 30, 2021 -0.2137
June 30, 2021 -0.1867
March 31, 2021 -0.2113
December 31, 2020 -0.169
September 30, 2020 -0.2295
June 30, 2020 -0.253
March 31, 2020 -0.3149
December 31, 2019 -0.3065
September 30, 2019 -0.2858
June 30, 2019 -0.4432
March 31, 2019 -0.4977
December 31, 2018 -0.6038
September 30, 2018 -0.4308
June 30, 2018 -0.33
March 31, 2018 -0.45
December 31, 2017 -0.2247
March 31, 2017 -8.907
December 31, 2016 -0.1118

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Omeros Corp. 0.1476
Talphera, Inc. -0.0571
ANI Pharmaceuticals, Inc. 1.052
Corcept Therapeutics, Inc. 0.356
Veru, Inc. -0.3032

EPS Diluted (Quarterly) Related Metrics